Neoplasias linfoides: comportamiento clínico-histológico en nuestro medio, evaluación de 316 casos
Lozano, Jorge; Cuéllar, Francisco; Sarmiento, Juan J; Maya, Luz M; Alvarez, María L; Murillo, Magda L.
Acta méd. colomb
; 19(1): 24-9, ene.-feb. 1994. tab
Artículo en Español | LILACS | ID: lil-292804
Documentos relacionados
[IgD expression in various immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma in children].
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
Late relapses in Hodgkin lymphoma - should we search for the needle in the haystack?
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach.
Unfavorable early-stage Hodgkin lymphoma: assessment of patient characteristics in a real-world setting.
Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years.
Immunotherapy in Hodgkin Lymphoma: The Road Ahead.
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
Barriers to long-term follow-up in pediatric Hodgkin lymphoma survivors.